Literature DB >> 12036499

Pituitary Adenomas.

Grant T. Liu1.   

Abstract

Treatment of pituitary adenomas can be pharmacologic or surgical. First- line treatment of prolactinomas is usually medical, using either bromocriptine or cabergoline. Other symptomatic pituitary adenomas typically should be treated with transsphenoidal surgery. Radiation therapy can be adjunctive for residual or recurrent tumor. The prognosis for endocrinologic and visual improvement is usually good.

Entities:  

Year:  2002        PMID: 12036499     DOI: 10.1007/s11940-002-0026-0

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  58 in total

Review 1.  Medical management of pituitary tumours.

Authors:  F P Alford; R Arnott
Journal:  Med J Aust       Date:  1992-07-06       Impact factor: 7.738

2.  Images in clinical medicine. Tumors of the pituitary, pancreas, and parathyroid glands in a patient with multiple endocrine neoplasia type 1.

Authors:  K J Simcic; A J Moreno
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

Review 3.  Pituitary adenomas: results of 684 surgically treated patients and review of the literature.

Authors:  H H Oruçkaptan; O Senmevsim; O E Ozcan; T Ozgen
Journal:  Surg Neurol       Date:  2000-03

4.  The efficacy of conventional radiation therapy in the management of pituitary adenoma.

Authors:  R Sasaki; M Murakami; Y Okamoto; K Kono; E Yoden; T Nakajima; S Nabeshima; Y Kuroda
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-15       Impact factor: 7.038

5.  Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.

Authors: 
Journal:  Clin Endocrinol (Oxf)       Date:  2000-06       Impact factor: 3.478

6.  Visual function in prolactinoma patients treated with bromocriptine.

Authors:  M L Moster; P J Savino; N J Schatz; P J Snyder; R C Sergott; T M Bosley
Journal:  Ophthalmology       Date:  1985-10       Impact factor: 12.079

Review 7.  Management of nonfunctioning pituitary adenomas.

Authors:  G Sassolas; J Trouillas; C Treluyer; G Perrin
Journal:  Acta Endocrinol (Copenh)       Date:  1993-07

8.  Dopamine agonists and pituitary tumor shrinkage.

Authors:  J S Bevan; J Webster; C W Burke; M F Scanlon
Journal:  Endocr Rev       Date:  1992-05       Impact factor: 19.871

Review 9.  Epidemiology and pathogenesis of pituitary adenomas.

Authors:  G Faglia
Journal:  Acta Endocrinol (Copenh)       Date:  1993-07

10.  Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas.

Authors:  M J Ebersold; L M Quast; E R Laws; B Scheithauer; R V Randall
Journal:  J Neurosurg       Date:  1986-05       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.